Trodelvy’s Phase III Breast Cancer Results Raise More Questions Than Answers

 
• By Alaric DeArment
  
Cancer cells on scientific background.3d illustration
Gilead announced results of the Phase III TROPiCS-02 study of Trodelvy in HR+/HER2- metastatic breast cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business